Richardson R - Search Results

1

Prolonged Effect of Zoledronic Acid on Bone Mineral Density and Turnover in HIV-Infected Adults on Tenofovir: A Randomized, Open-Label Study.

Carr A, Kerr SJ, Richardson R, Ebeling P, Pocock N, Rojas J, Martinez E, Hoy J; ZEST study Investigators. Carr A, et al. Among authors: richardson r. J Bone Miner Res. 2019 Dec;34(12):2192-2197. doi: 10.1002/jbmr.3834. Epub 2019 Oct 24. J Bone Miner Res. 2019. PMID: 31361922 Free article. Clinical Trial.

2

Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV.

Hoy JF, Richardson R, Ebeling PR, Rojas J, Pocock N, Kerr SJ, Martinez E, Carr A; ZEST Study Investigators. Hoy JF, et al. Among authors: richardson r. AIDS. 2018 Sep 10;32(14):1967-1975. doi: 10.1097/QAD.0000000000001911. AIDS. 2018. PMID: 29927785 Clinical Trial.

3

Lower arterial stiffness and Framingham score after switching abacavir to tenofovir in men at high cardiovascular risk.

Sinn K, Richardson R, Carr A. Sinn K, et al. Among authors: richardson r. AIDS. 2010 Sep 24;24(15):2403-5. doi: 10.1097/QAD.0b013e32833d568f. AIDS. 2010. PMID: 20647907

4

Success and failure of initial antiretroviral therapy in adults: an updated systematic review.

Carr A, Richardson R, Liu Z. Carr A, et al. Among authors: richardson r. AIDS. 2019 Mar 1;33(3):443-453. doi: 10.1097/QAD.0000000000002077. AIDS. 2019. PMID: 30475265

5

Switch from tenofovir disoproxil fumarate to raltegravir is not associated with weight gain over 96 weeks.

Carr M, Richardson R, Tong W, Bloch M, Baker D, Hoy JF; TROP Study Team. Carr M, et al. Among authors: richardson r. AIDS. 2020 Apr 1;34(5):789-790. doi: 10.1097/QAD.0000000000002473. AIDS. 2020. PMID: 31895147

6

Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks.

Bloch M, Tong WW, Hoy J, Baker D, Lee FJ, Richardson R, Carr A; TROP (Switch from Tenofovir to Raltegravir for Low Bone Density) study team. Bloch M, et al. Among authors: richardson r. HIV Med. 2014 Jul;15(6):373-80. doi: 10.1111/hiv.12123. Epub 2014 Jan 26. HIV Med. 2014. PMID: 24460797 Free article.

7

Postprandial lipid effects of low-dose ritonavir vs. raltegravir in HIV-uninfected adults.

Samaras K, Richardson R, Carr A. Samaras K, et al. Among authors: richardson r. AIDS. 2010 Jul 17;24(11):1727-31. doi: 10.1097/QAD.0b013e32833ac7be. AIDS. 2010. PMID: 20588105 Clinical Trial.

8

Single-Tablet Emtricitabine-Rilpivirine-Tenofovir as HIV Postexposure Prophylaxis in Men Who Have Sex With Men.

Foster R, McAllister J, Read TR, Pierce AB, Richardson R, McNulty A, Carr A. Foster R, et al. Among authors: richardson r. Clin Infect Dis. 2015 Oct 15;61(8):1336-41. doi: 10.1093/cid/civ511. Epub 2015 Jun 29. Clin Infect Dis. 2015. PMID: 26123937 Clinical Trial.

9

Dolutegravir with tenofovir disoproxil fumarate-emtricitabine as HIV postexposure prophylaxis in gay and bisexual men.

McAllister JW, Towns JM, Mcnulty A, Pierce AB, Foster R, Richardson R, Carr A. McAllister JW, et al. Among authors: richardson r. AIDS. 2017 Jun 1;31(9):1291-1295. doi: 10.1097/QAD.0000000000001447. AIDS. 2017. PMID: 28301425

10

Socioeconomic and psychosocial factors are associated with poor treatment outcomes in Australian adults living with HIV: a case-control study.

Siefried KJ, Kerr S, Richardson R, Mao L, Rule J, McAllister J, de Wit J, Carr A. Siefried KJ, et al. Among authors: richardson r. Sex Health. 2019 Nov;16(6):548-553. doi: 10.1071/SH18138. Sex Health. 2019. PMID: 31514798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,575 results

Search Page

Filters